Movement Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Movement Disorders stocks.

Movement Disorders Stocks Recent News

Date Stock Title
May 14 OMER Omeros Q1 2024 Earnings Preview
May 14 MDT Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
May 14 MDT Medtronic Among America's Best Companies for Workplace Fairness
May 14 NBIX Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024
May 14 MDT Medtronic: Looking Ahead To FY 2025 EPS Growth, Shareholder Friendly Actions
May 13 MDT Medtronic (MDT) Advances While Market Declines: Some Information for Investors
May 13 MDT Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13 JAZZ Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA
May 13 MDT 14 Best Long-Term Dividend Stocks To Buy Now
May 13 MDT Medtronic plc (NYSE:MDT) is largely controlled by institutional shareholders who own 86% of the company
May 10 JAZZ Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug (update)
May 10 MDT Here's How Medtronic (MDT) Is Placed Ahead of Q4 Earnings
May 10 OMER Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
May 9 NBIX How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
May 9 MDT Medtronic Recognized for Health Monitoring Innovation in 8th Annual MedTech Breakthrough Awards Program
May 9 NBIX Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024
May 9 JAZZ 7 Cannabis Stocks to Buy for a Smoking-Hot 2024
May 9 MDT Medtronic: Managing Her Diabetes ‘Runner’s High’
May 9 OMER Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
May 9 MDT Medtronic to announce financial results for its fourth quarter and full fiscal year 2024
Movement Disorders

Movement disorders are clinical syndromes with either an excess of movement or a paucity of voluntary and involuntary movements, unrelated to weakness or spasticity. Movement disorders are synonymous with basal ganglia or extrapyramidal diseases. Movement disorders are conventionally divided into two major categories- hyperkinetic and hypokinetic.
Hyperkinetic movement disorders refer to dyskinesia, or excessive, often repetitive, involuntary movements that intrude upon the normal flow of motor activity.
Hypokinetic movement disorders refer to akinesia (lack of movement), hypokinesia (reduced amplitude of movements), bradykinesia (slow movement) and rigidity. In primary movement disorders, the abnormal movement is the primary manifestation of the disorder. In secondary movement disorders, the abnormal movement is a manifestation of another systemic or neurological disorder.

Browse All Tags